Health Insurance
Health insurance news and analysis, with coverage of general health insurance trends, major medical insurance, disability insurance, dental insurance, vision plans, telemedicine plans, critical illness insurance, hospital indemnity insurance, short-term health insurance, the Affordable Care Act public exchange program, and more.
Week in Pictures | May 18, 2012
By Michael K. StanleyJPMorgan gets some egg on its face, N.J.'s Governor Chris Christie deep-sixes his state's health exchange plan, and Facebook's IPO rocks the markets. All this and more in this week's Week in Pictures.
May 17, 2012
SRI Investor Coalition Tells Shale Energy Companies to Clean Up Their ActA coalition of investors committed to environmental stewardship and corporate responsibility are using their combined $1 trillion in assets to pressure energy companies to adhere to best practices in fracking shale oil gas.
May 17, 2012
On the Third Hand: Provider DirectoriesThe current provider directory mess makes everyone angry and makes both providers and insurers look terrible.
May 17, 2012
CMS Seeks Comments on PPACA Exchange Application ProcessOfficials are putting a PPACA exchange "blueprint for approval process" and a grant application process through paperwork reviews.
May 17, 2012
PPACA: NAIC Panel Eyes Network AdequacyConsumer reps suggest PPACA could give insurers an incentive to cut costs by offering enrollees skimpy networks.
May 17, 2012
CMS Seeks Comments on PPACA Exchange Application ProcessOfficials are putting a PPACA exchange "blueprint for approval process" and a grant application process through paperwork reviews.
May 17, 2012
PwC Survey: Drug Manufacturers Must Demonstrate Clinical, Economic Benefits of ProductsA shift in consumer and provider preferences could hurt revenues for drug manufacturers that dont speed efforts to demonstrate the clinical and economic benefits of their products, according to a new PricewaterhouseCoopers survey.
May 17, 2012
PwC Survey: Drug Manufacturers Must Demonstrate Clinical, Economic Benefits of ProductsA shift in consumer and provider preferences could hurt revenues for drug manufacturers that dont speed efforts to demonstrate the clinical and economic benefits of their products, according to a new PricewaterhouseCoopers survey.